This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in the country.
Corbevax is currently being used to inoculate children against COVID-19 in the age group of 12 to 14 years.
Covid-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad, the Union health ministry said.
NTAGI's Standing Technical Sub-Committee (STSC), however, couldn’t arrive at a decision on introducing Corbevax and Covaxin in the vaccination programme.
The countrywide vaccination drive was rolled out on January 16 last year with healthcare workers getting inoculated in the first phase. Vaccination of frontline workers started from February 2 last year.
Covid-19: The India has approved the use of Corbevax and Covovax against the virus, while the anti-viral drug Molnupiravir has been given approval to be used in emergency situations.
Biological E Limited's COVID-19 vaccine, Corbevax, becomes the first heterologous COVID-1 booster vaccine that has been approved by the Drug Controller General of India (DGCI) for emergency situations.
Corbevax has completed two Phase III clinical trials involving more than 3000 subjects between the ages of 18 and 80 at 33 study sites across India.
All the recommendations of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) have been sent to the Drugs Controller...
Mahima Datla, Managing Director, Biological E. Limited, said these approvals would help support its subsequent filings with the World Health Organization (WHO)...